Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Stereotactic body radiotherapy for colorectal liver metastases
297
Zitationen
11
Autoren
2011
Jahr
Abstract
Liver stereotactic body radiotherapy is well tolerated and effective for colorectal liver metastases. The strong correlation between local control and OS supports controlling hepatic disease even for heavily pretreated patients. For a 3-fraction regimen of stereotactic body radiotherapy, a prescription dose of ≥ 48 Gy should be considered, if normal tissue constraints allow.
Ähnliche Arbeiten
Sorafenib in Advanced Hepatocellular Carcinoma
2008 · 12.882 Zit.
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 · 11.391 Zit.
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
2004 · 10.949 Zit.
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
2005 · 10.579 Zit.
Management of Hepatocellular Carcinoma: An Update Δσ
2011 · 8.105 Zit.